Heron Announces Positive Topline Results from Phase 2b Clinical Studies of HTX-011 in Total Knee Arthroplasty and Breast Augmentation
Go back to Heron Announces Positive Topline Results from Phase 2b Clinical Studies of HTX-011 in Total Knee Arthroplasty and Breast Augmentation| HERON THERAPEUTICS (NASDAQ: HRTX) | Delayed: 0.42 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.42 | 52 Week High | $31.32 | |||
| Open | $0.42 | 52 Week Low | $13.95 | |||
| Day High | $0.42 | P/E | N/A | |||
| Day Low | $0.42 | EPS | $-3.29 | |||
| Volume | 30,460 | |||||
